510(k) · Cleared
ClearedTranscranial Electrotherapy Stimulator-a, Model Tesa-1
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Kalaco Scientific, Inc. · QJQ Cranial Electrotherapy Stimulator To Treat Insomnia And/Or Anxiety
Cleared on Jul 21, 2003 as substantially equivalent to K903654 (Medical Consultants Intl., Ltd., 1990) and 1 other predicate after a 202-day review. Its family tree reaches back 1 generation to 1988.
- Decided
- Jul 21, 2003
- Review
- 202 days
- Class
- Class II
- Product code
- QJQ
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 1 generation to K883812 (1988). 2 ancestors in all. No later device cites it as a predicate yet.
- Root · 1 generation backK883812 HP-1 (Healthpax)Healthdirections, Inc. · 1988 · Recalled
- This deviceK024377 Transcranial Electrotherapy Stimulator-a, Model Tesa-1Kalaco Scientific, Inc. · 2003
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K883812 | HP-1 (Healthpax) | Healthdirections, Inc. | 1988 | 1 |
| 0 (this device) | K024377 | Transcranial Electrotherapy Stimulator-a, Model Tesa-1 | Kalaco Scientific, Inc. | 2003 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1990 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in QJQ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new QJQ device
- #1 K252951 Genesis Sleepscore 11.2 · 3 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (3)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K903654 | Liss Cranial Stimulator Model SBL202-BSummary page 1…. _ _ _ Liss Cranial Stimulator, SBL202-B K903654 HealthPax HP-1 K883812 Description of the Device and Summar… | 1990 |
| * | K883812 | HP-1 (Healthpax)Summary page 1…Liss Cranial Stimulator, SBL202-B K903654 HealthPax HP-1 K883812 Description of the Device and Summary of the Technological Characteristics: The TESA is a transcranial electrotherapy stimulat… | 1988 |
| * | — | Alpha-Stim CS Named without a submission number |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- 2 of the 2 ancestors have a recall of any class.
How does its category compare?
All QJQ devicesQJQ Cranial Electrotherapy Stimulator To Treat Insomnia And/Or Anxiety: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · QJQ
1in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · QJQ
Too few QJQ 510(k)s in any year since 2007 to give a median.
Recalls per year · QJQ
No recall names QJQ since 2007.
Adverse event reports per year · QJQ
39in 2023
MAUDE reports naming product code QJQ, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 1 | — | 0 | 0 |
| 2008 | 1 | — | 0 | 0 |
| 2009 | 1 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 1 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 1 | — | 0 | 39 |
| 2024 | 1 | — | 0 | 0 |
| 2025 | 1 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
Treatment with the TESA device is intended to reduce the symptoms of depression, anxiety and insomnia.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K024377 · printed Nov 3, 2026
Cite this page
510(k) Report. “K024377: Transcranial Electrotherapy Stimulator-a, Model Tesa-1.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K024377
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026